SIMCERE PHARMAC Valuation
| S2P Stock | EUR 0.89 0.05 5.95% |
Today, the company appears to be overvalued. SIMCERE PHARMAC GRP has a current Real Value of €0.7 per share. The regular price of the company is €0.89. Our model measures the value of SIMCERE PHARMAC GRP from examining the company fundamentals such as shares owned by insiders of 69.20 %, and Return On Equity of 0.17 as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that SIMCERE PHARMAC's price fluctuation is extremely dangerous at this time. Calculation of the real value of SIMCERE PHARMAC GRP is based on 3 months time horizon. Increasing SIMCERE PHARMAC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SIMCERE stock is determined by what a typical buyer is willing to pay for full or partial control of SIMCERE PHARMAC GRP. Since SIMCERE PHARMAC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SIMCERE Stock. However, SIMCERE PHARMAC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.89 | Real 0.7 | Hype 0.89 | Naive 0.91 |
The real value of SIMCERE Stock, also known as its intrinsic value, is the underlying worth of SIMCERE PHARMAC GRP Company, which is reflected in its stock price. It is based on SIMCERE PHARMAC's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SIMCERE PHARMAC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of SIMCERE PHARMAC GRP helps investors to forecast how SIMCERE stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SIMCERE PHARMAC more accurately as focusing exclusively on SIMCERE PHARMAC's fundamentals will not take into account other important factors: SIMCERE PHARMAC Total Value Analysis
SIMCERE PHARMAC GRP is at this time estimated to have takeover price of 0 with market capitalization of 3.75 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the SIMCERE PHARMAC fundamentals before making investing decisions based on enterprise value of the companySIMCERE PHARMAC Asset Utilization
One of the ways to look at asset utilization of SIMCERE is to check how much profit was generated for every dollar of assets it reports. SIMCERE PHARMAC GRP exercises its assets roughly 0.0344 %, attaining 0.0344 cents for each euro of assets held by the company. A flourishing asset utilization indicates the company is being more competent with each euro of assets it has. In other words, asset utilization of SIMCERE PHARMAC shows how competent it operates for each euro spent on its assets.SIMCERE PHARMAC Ownership Allocation
SIMCERE PHARMAC GRP shows a total of 2.66 Billion outstanding shares. SIMCERE PHARMAC GRP has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.2 % of SIMCERE PHARMAC outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates SIMCERE PHARMAC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in SIMCERE PHARMAC and how it compares across the competition.
About SIMCERE PHARMAC Valuation
The stock valuation mechanism determines SIMCERE PHARMAC's current worth on a weekly basis. Our valuation model uses a comparative analysis of SIMCERE PHARMAC. We calculate exposure to SIMCERE PHARMAC's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of SIMCERE PHARMAC's related companies.8 Steps to conduct SIMCERE PHARMAC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates SIMCERE PHARMAC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct SIMCERE PHARMAC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain SIMCERE PHARMAC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine SIMCERE PHARMAC's revenue streams: Identify SIMCERE PHARMAC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research SIMCERE PHARMAC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish SIMCERE PHARMAC's growth potential: Evaluate SIMCERE PHARMAC's management, business model, and growth potential.
- Determine SIMCERE PHARMAC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate SIMCERE PHARMAC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for SIMCERE Stock analysis
When running SIMCERE PHARMAC's price analysis, check to measure SIMCERE PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIMCERE PHARMAC is operating at the current time. Most of SIMCERE PHARMAC's value examination focuses on studying past and present price action to predict the probability of SIMCERE PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIMCERE PHARMAC's price. Additionally, you may evaluate how the addition of SIMCERE PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |